A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma

NCT05556616 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped Due to strategic reasons (no safety concerns).

Conditions

Multiple Myeloma

Interventions

DRUG: Modakafusp alfa
DRUG: Lenalidomide
DRUG: Bortezomib
DRUG: Carfilzomib
DRUG: Daratumumab
DRUG: Pomalidomide

Sponsor

Teva Branded Pharmaceutical Products R&D LLC